Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 3346-3350

  Keulen, W ^a   Back, N K T ^a   Van Wijk, A ^a   Boucher, C A B ^a   Berkhout, B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; DRUG RESISTANCE; GENETIC SELECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS RESISTANCE;

EID: 0030896362     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.3346-3350.1997     Document Type: Article

References (36)